AS

Anita Sudhir Deulgaonkar

Director Director DIN 07254575
DIN 07254575 First appointment Dec 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2015
Shareholding value •••• Premium profile

About Anita Sudhir Deulgaonkar

Data last updated:

Anita Sudhir Deulgaonkar was a Director at Snehal Pharma & Surgicals Private Limited (2015–2021) and Director at Mas Infraway Private Limited (2016–2017). The companies operate in Pharma and Business Services.

DIN 07254575
Primary Designation Director
Industry Pharma
First Appointment 11 Dec 2015

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Dec 20152011₹20.74 Cr (FY 2024)Active
Mas Infraway Private Limited U70100MH2016PTC271683
Director05 Jan 20162016₹64,107 (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Snehal Pharma & Surgicals Private Limited
Mas Infraway Private Limited
Premium access

Shareholding and investment profile for Anita Sudhir Deulgaonkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Sudhir Deulgaonkar

Anita Sudhir Deulgaonkar was first appointed on 11 Dec 2015 as Director at Snehal Pharma & Surgicals Private Limited. The most recent appointment on record is 05 Jan 2016 at Mas Infraway Private Limited.

Anita Sudhir Deulgaonkar held 2 earlier board appointments: Snehal Pharma & Surgicals Private Limited (Director, 11 Dec 2015 to 04 Feb 2021); Mas Infraway Private Limited (Director, 05 Jan 2016 to 01 Oct 2017).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available